Patent classifications
C07C2601/06
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
Prodrugs of gamma-hydroxybutyric acid, compositions and uses thereof
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
PRODRUGS OF GAMMA-HYDROXYBUTYRIC ACID, COMPOSITIONS AND USES THEREOF
The present disclosure discloses prodrugs of gamma-hydroxybutyric acid as well as compositions and uses thereof.
Process for conversion of acyclic C5 compounds to cyclic C5 compounds and catalyst composition for use therein
Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprising the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a crystalline aluminosilicate having a constraint index of less than or equal to 5, and a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.
BACE1 inhibitors for the treatment of Alzheimer's disease
Described herein are compounds of the formulae (I)-(III) as well as pharmaceutical compositions comprising such compounds and methods for using such compounds/pharmaceutical compositions for treating Alzheimer's disease.
Azeotropic Compositions Comprising Hydrogen Fluoride and Fluorocarbons
The present application discloses compositions comprising hydrogen fluoride and fluorinated compounds (e.g., hydrochlorofluorocarbons), wherein the fluorinated compound is present in the composition in an amount effective to form an azeotrope composition or azeotrope-like composition with the hydrogen fluoride.
Cyclobenzoins
One-step cyanide-catalyzed benzoin condensations for synthesizing shape persistent cyclobenzoin macrocycles. Selected dialdehydes, and cyanide salts are reacted in aqueous solvents to form such cyclobenzoin macrocycles.
PERFUME SYSTEMS
The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities' options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.
Process for conversion of acyclic C5 compounds to cyclic C5 compounds and catalyst composition for use therein
Disclosed is a process for the conversion of acyclic C.sub.5 feedstock to a product comprising cyclic C.sub.5 compounds, such as, for example, cyclopentadiene, and catalyst compositions for use in such process. The process comprises the steps of contacting said feedstock and, optionally, hydrogen under acyclic C.sub.5 conversion conditions in the presence of a catalyst composition to form said product. The catalyst composition comprising a microporous crystalline aluminosilicate having a constraint index in the range of 3 to 12, a Group 10 metal, and, optionally, a Group 11 metal, in combination with a Group 1 alkali metal and/or a Group 2 alkaline earth metal.